Form 4: ANI Pharmaceuticals Executive Meredith Cook Sells 400 Shares

Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 400 shares of common stock on May 13, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On May 13, 2025, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 400 shares of common stock at a price of $62.2 per share.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on September 17, 2024.
• Following the transaction, Meredith Cook directly owns 79,745 shares of ANI Pharmaceuticals.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing for an insider stock sale. It doesn't inherently convey positive or negative sentiment, as it's simply a report of a transaction.

Industry Context

This is a routine disclosure of an insider transaction. Rule 10b5-1 plans are common mechanisms for corporate insiders to sell shares without raising concerns about trading on non-public information.

Stakeholder Impact

• The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale, but is unlikely to have a significant impact due to the relatively small number of shares sold.

Key Dates

Keywords

ANI Pharmaceuticals, Meredith Cook, Form 4, insider trading, stock sale, Rule 10b5-1, ANIP